FREE DOWNLOAD Three cholinesterase inhibitors, donepezil, galantamine and rivastigmine, are widely used as symptomatic treatment of Alzheimer's disease. Their minimal benefits do not justify exposing patients to the risk of syncope and bradycardia, and their consequences. These drugs should simply be avoided and the emphasis placed on non-drug management, however difficult.
Full text available for free download.